Display Settings:

Format

Send to:

Choose Destination
    Antimicrob Agents Chemother. 2004 Jul;48(7):2742-6.

    In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.

    Source

    Mycetoma Research Group, Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.

    Abstract

    Susceptibilities of Madurella mycetomatis against amphotericin B and itraconazole in vitro were determined by protocols based on NCCLS guidelines (visual reading) and a 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide (XTT) assay for fungal viability. The XTT assay was reproducible and sensitive for both antifungals. Itraconazole (MIC at which 50% of the isolates tested are inhibited [MIC(50)]) of 0.06 to 0.13 mg/liter) was superior to amphotericin B (MIC(50) of 0.5 to 1.0 mg/liter).

    PMID:
    15215141
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC434196
    Free PMC Article

    Images from this publication.See all images (2) Free text

    FIG. 1.
    FIG. 2.

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk